Biomerica Inc BMRA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 4.60M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 50
- Website
- https://www.biomerica.com
Valuation
|
Metric
|
BMRA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.23 |
Price/Sales | 1.20 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BMRA
|
|---|---|
Quick Ratio | 0.84 |
Current Ratio | 1.62 |
Interest Coverage | — |
Quick Ratio
BMRA
Profitability
|
Metric
|
BMRA
|
|---|---|
Return on Assets (Normalized) | −60.12% |
Return on Equity (Normalized) | −93.26% |
Return on Invested Capital (Normalized) | −99.38% |
Return on Assets
BMRA
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|l>Y<<& | LOCK|v@Kj | $172B | |||
| Medtronic PLC
MDT
| LOCK|>G@^?S | LOCK|HKr@ | $113B | |||
| Stryker Corp
SYK
| LOCK|YD<$ZWxJ | LOCK|#&C | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|mQp?HX | LOCK|F&#$ | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|jK@pQfH^ | LOCK|%%Bgh | $49B | |||
| DexCom Inc
DXCM
| LOCK|@gfG^h< | LOCK|<PG! | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|w?^?vh | LOCK|TV | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|vz& | LOCK|#&j | $24B | |||
| Steris PLC
STE
| LOCK|M@q%KZ | LOCK|XX>Z | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|F^b@qC>b | LOCK|p> | $17B |
United States